Cargando…

Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil

The applicant Syngenta submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The applicant provided residue...

Descripción completa

Detalles Bibliográficos
Autores principales: Anastassiadou, Maria, Brancato, Alba, Carrasco Cabrera, Luis, Ferreira, Lucien, Greco, Luna, Jarrah, Samira, Kazocina, Aija, Leuschner, Renata, Magrans, Jose Oriol, Miron, Ileana, Nave, Stefanie, Pedersen, Ragnor, Reich, Hermine, Rojas, Alejandro, Sacchi, Angela, Santos, Miguel, Stanek, Alois, Theobald, Anne, Vagenende, Benedicte, Verani, Alessia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009037/
https://www.ncbi.nlm.nih.gov/pubmed/32626430
http://dx.doi.org/10.2903/j.efsa.2019.5812
_version_ 1783495576601493504
author Anastassiadou, Maria
Brancato, Alba
Carrasco Cabrera, Luis
Ferreira, Lucien
Greco, Luna
Jarrah, Samira
Kazocina, Aija
Leuschner, Renata
Magrans, Jose Oriol
Miron, Ileana
Nave, Stefanie
Pedersen, Ragnor
Reich, Hermine
Rojas, Alejandro
Sacchi, Angela
Santos, Miguel
Stanek, Alois
Theobald, Anne
Vagenende, Benedicte
Verani, Alessia
author_facet Anastassiadou, Maria
Brancato, Alba
Carrasco Cabrera, Luis
Ferreira, Lucien
Greco, Luna
Jarrah, Samira
Kazocina, Aija
Leuschner, Renata
Magrans, Jose Oriol
Miron, Ileana
Nave, Stefanie
Pedersen, Ragnor
Reich, Hermine
Rojas, Alejandro
Sacchi, Angela
Santos, Miguel
Stanek, Alois
Theobald, Anne
Vagenende, Benedicte
Verani, Alessia
collection PubMed
description The applicant Syngenta submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The applicant provided residue trials on strawberries representative for an adjusted Good Agricultural Practice (GAP) and a new feeding study in ruminants. The data gaps identified in the MRL review were considered satisfactorily addressed, except for the southern adjusted GAP on strawberries. The new residue data confirm the existing tentative MRL for strawberries; EFSA proposed – based on the new feeding study in ruminants – amendments of the existing MRLs for certain animal products for further risk management consideration. EFSA updated the most recent consumer risk assessment for fludioxonil and concluded that the long‐term dietary intake is unlikely to present a risk to consumer health.
format Online
Article
Text
id pubmed-7009037
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70090372020-07-02 Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil Anastassiadou, Maria Brancato, Alba Carrasco Cabrera, Luis Ferreira, Lucien Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Rojas, Alejandro Sacchi, Angela Santos, Miguel Stanek, Alois Theobald, Anne Vagenende, Benedicte Verani, Alessia EFSA J Reasoned Opinion The applicant Syngenta submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The applicant provided residue trials on strawberries representative for an adjusted Good Agricultural Practice (GAP) and a new feeding study in ruminants. The data gaps identified in the MRL review were considered satisfactorily addressed, except for the southern adjusted GAP on strawberries. The new residue data confirm the existing tentative MRL for strawberries; EFSA proposed – based on the new feeding study in ruminants – amendments of the existing MRLs for certain animal products for further risk management consideration. EFSA updated the most recent consumer risk assessment for fludioxonil and concluded that the long‐term dietary intake is unlikely to present a risk to consumer health. John Wiley and Sons Inc. 2019-09-17 /pmc/articles/PMC7009037/ /pubmed/32626430 http://dx.doi.org/10.2903/j.efsa.2019.5812 Text en © 2019 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.
spellingShingle Reasoned Opinion
Anastassiadou, Maria
Brancato, Alba
Carrasco Cabrera, Luis
Ferreira, Lucien
Greco, Luna
Jarrah, Samira
Kazocina, Aija
Leuschner, Renata
Magrans, Jose Oriol
Miron, Ileana
Nave, Stefanie
Pedersen, Ragnor
Reich, Hermine
Rojas, Alejandro
Sacchi, Angela
Santos, Miguel
Stanek, Alois
Theobald, Anne
Vagenende, Benedicte
Verani, Alessia
Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil
title Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil
title_full Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil
title_fullStr Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil
title_full_unstemmed Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil
title_short Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil
title_sort evaluation of confirmatory data following the article 12 mrl review for fludioxonil
topic Reasoned Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009037/
https://www.ncbi.nlm.nih.gov/pubmed/32626430
http://dx.doi.org/10.2903/j.efsa.2019.5812
work_keys_str_mv AT evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT anastassiadoumaria evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT brancatoalba evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT carrascocabreraluis evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT ferreiralucien evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT grecoluna evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT jarrahsamira evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT kazocinaaija evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT leuschnerrenata evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT magransjoseoriol evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT mironileana evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT navestefanie evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT pedersenragnor evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT reichhermine evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT rojasalejandro evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT sacchiangela evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT santosmiguel evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT stanekalois evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT theobaldanne evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT vagenendebenedicte evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil
AT veranialessia evaluationofconfirmatorydatafollowingthearticle12mrlreviewforfludioxonil